- Prof. Dr. Juergen Simon and Cristina Blohm-Seewald, M.A.
Institut fur Rechtswissenshaften,
Universitat Luneburg,
D-21332 Luneburg, GERMANY
Email: simon@euroacademy.com
Eubios Journal of Asian and International Bioethics 14 (2004), 199-203.
This paper
concerns a regulatory model, which regards populations as market participants
with adequately shared property rights. This model is generally considered as a
fairly basic one within a globalized world and might thus serve as a starting
point from which further forms of participation and cooperation as
market-immanent structures develop. We are starting out from the very broad
division into two different worlds: An industrialised one on the one hand and
the so-called developing countries on the other. The following assumptions
underlie this model:
1st Thesis:
The conflict about the regulation
of access to genetic resources as well as access and benefit sharing within
industrialised nations differs significantly from the conflict existing between industrialised
nations and the developing countries.
The latter
moreover being a historical conflict whose roots date back to the colonisation
era having been carried over into current times. Especially through a
continuation of exploitation and forced ownership practices by industrialised
nations regarding indigenous genetic and intellectual resources and the run on
human genetic resources of indigenous population[3], without any adequate consideration
and compensation of the interests of indigenous communities concerned, this
conflict has become more intense[4]. The escalation of any conflict may
lead to a hardening of positions that make a turn-around of the processes
concerned very difficult. In the most extreme this escalation reaches a ăpoint
of no return". In conjunction with the setting up of bigger national biobanks
over the last couple of years a sometimes fairly fierce debate around the legal
and ethical problems of access to these has ensued within the industrialised
nations themselves. This discussion enters upon the various forms of access to
humane genetic resources from within the population and the subsequent socially
fair way of compensation; however, without reaching the degree of escalation
concerning the other conflict described earlier.
Conflicts
as social phenomena are inherent to any social structure and as such exhibit
both negative as well as positive characteristics. Generally speaking a
positive aspect of conflicts is the widespread discussion around them, arising
mostly from the grievances and misunderstandings, which caused the conflict.
Considering the corresponding populations the chance meant before could be the
opportunity to develop creative possibilities of conflict solution. For the
parties involved, conflicts are therefore a challenge to introduce the
necessary social changes in a carefully directed and guided form. The solution
of the conflict about the regulation of the access to genetic resources and
benefit sharing between industrial and developing nations is a global
challenge, which can only be coped with through a collective effort of the
community of states. To fulfil the difficulty about access and benefit sharing
an approach that considers the specific culture values is essential. Neither
the conceptions about access nor those about benefit sharing are valid all over
the world and therefore not comparable.[5] Especially benefit sharing is
marked by the properties, subjectivity and immeasurableness what means that there
are no "objective standards ... to measure benefit and to compare the benefit
which is reached by different people". The lack of such scales makes it very
difficult to find a universal solution for this problem.[6]
Concerning
the conflicts in the periphery of access and benefit sharing mentioned it would
be a challenge to reconsider and deform the existing rights of disposal.
2nd Thesis
Actors and actions are dominated
in the "industrialised world" by an economic orientation. The economic
calculation in terms of aspiration for individual profit dominates the reasons
for acting. Economically oriented acting does not preclude the maintenance of
ethic, social and ecological principles which are immanently given.
Biobanks
are a typical example for immanent social and ethic principles in terms of the
discussion about informed consent and therefore for indirect benefit sharing.
The focus here lies on legal and ethic forms of organisation in agreement to
the collection, storage and utilisation of data as well as the allocation of
texture and cells from the donors. These are of course individually assigned to
the donors before separation in into property rights. Traditionally
these rights lose their function as property rights for the donor with the
integration into a biodatabank because of being involved in the database by
default. Normally, the donors pass on their rights for the benefit of the bank,
the industry or the researcher. After a "normal" declaration of consent certain
rights still remain with the donor such as rights over control and destruction
of data. If somebody gives a blank acceptance these rights are mostly lapsed.
The different forms of consent are realised in practice as emptied-out rites
during which both sides of the conflict are lead to their aimed conclusions:
One part dispenses and another is allowed to work for his own and the benefit
of others if research is successful. That is why it has come to a conventional
direct reallocation of disposal rights in favour of the pharmaceutical industry
and indirectly – concerning the future possibility of medical results
– in aid of a benefit for the donors as well. In case of successful drug
development the community of patients will profit from the donation even if the
donor himself has no direct earning at all (this problem comes up again if
less-developed-countries or purely indigenous communities are affected). From
this point of view however the focus lies on the industrialised countries.
If
continuing to think along this way informed consent, despite its apparently
emptied-out non-significance, through its latent structure quasi-automatically
transports benefit sharing with it. In other words: Every time genetic data is
allocated to researchers for another use there is the chance to share positive
results with the whole community on one hand. On the other hand this positive
abnegation of individuals is washed out and apparently limited through the
expansion of property rights of the business. "Apparently limited" should mean
that the knowledge about the results is now demarcated alongside monetary
equivalents. The donor gives up his property rights for the benefit of the
industrial side of the transaction. From the view of the business they fulfil a
process of collecting the given material and data because of research and
because of taking the risk of capital investment. This is why generally an
adequate return of invest can be realised and thus also should be debated under
ethical aspects.
There is a
common consensus about the necessity of the conservation of the genetic
diversity because of its existential importance for humankind and for the
following generations. The loss of genetic diversity is irreversible. That
means that a living space once damaged or the breed, which is destroyed, is
"lost forever" – hand in hand with the destruction of diversity there
will be a demolition of the connected economic potential.[7] It is for this reason protection
and preservation of genetic diversity should be the prior principle leading the
actions. This principle is also valid for the use of human genetic diversity.
Preservation and diversity of life are to elevate to the most important
principle for academic work and the connected economic activities. If research
is done within the own population, then this "humanitarian" principle is not
only immanent existent, but explicit destination of population orientated
biobanks.
Things
look differently if research is done by industrial nations in communities
abroad for example in indigenous communities. In the face of the now discharged
Human Genome Diversity Project (HGDP) the indignation of the indigenous facing
the HGDP is comprehensible.[8] The research had no pertinence for
the people chosen by this project; it was of no importance for the conservation
of endangered populations. The research objectives did not include their social
cultural reality but corresponded – from their perspective – with
the ethnocentrically behaviour of the dominant population. The official
denouncing of the project by indigenous representatives and organisations was
focused mainly on one goal of the HPGD which was called "immortalization of
cell lines", which means, to collect and store the genetic material of
populations before they disappear. Even if the problem here is mainly a
linguistic one because: "English terms such as 'immortalization' of cell lines
can be badly misunderstood" [RAFI 1993, p. 2]. It is not difficult to
imagine that members of a small group being told that samples are needed
because they are endangered would be deeply offended, and it is unlikely that
they would take much comfort from being told that they are making an important
contribution to the advancement of scientific knowledge about the human body"
(IDRC 2003: 7).
The
cultural and ethical insensitive modus operandi of the project leaders and the ethnocentric
direction of the research goals (the history of the developing of Homo
sapiens, the genetic diversity of humankind, the aetiology of diseases
mainly found in the western world) of the project have aroused great resistance,
scepticism and displeasure among indigenous organisations. The afresh
subjugation in the form of degradation of the indigenous to objects of
research, the reduction of indigenous to extra precious data material to a
resource of research and the bizarre expectation that the marginalized
indigenous – formerly being suppressed and exploited by colonisation
– would consider altruistic motifs for the welfare of the western world
and to take therefore part in the project, harmed and disgusted the indigenous
populations. Primarily the danger of increasing the economic exploitation of
the people through commercialisation and the possibility of patent on their
indigenous genomes on the part of the dominant countries without adequate
consideration and respect of indigenous ethic-religious mental attitude towards
life and the human body (forbiddance of a patent of life) and without a
cultural adequate and equitable participation of indigenous, led to an almost
complete refusal of the 722 populations and to an official condemnation by the
World Council of lndigenous Peoples. In reference of the benefits of biobanks
for the population of industrial nations we have to consider that many in
indigenous communities do not perceive a benefit.
The
indirect benefit for the western donors exists - as described above - in the
possibility of being available to have and to make use of the potential
positive results from the biobank research in the case of diseases. But these
possibilities are irrelevant for the indigenous. The research objective of
biobanks is mainly focused on the so-called "Volkskrankheiten"[9] or in the industrialised nations
common diseases from the cardiovascular system (e.g. high blood pressure),
metabolism failure, hormone diseases (diabetes, osteoporosis) cancer, illnesses
of the nervous system, infectious- and immune diseases[10], diseases which have different
frequencies among (marginalized) indigenous communities.
The
reality in the developing countries, especially in the indigenous communities
is, following the opinion of the WHO, completely different: "In many developing
countries, health systems are in disarray because of long-standing
underinvestment, and cannot provide even basic coverage, in particular at the
periphery and for the most disadvantaged in terms of human development.
Marginalized ethnic populations, often distanced both physically and culturally
from mainstream society, face additional difficulties in accessing effective
and culturally appropriate health care. In developing countries, marginalized
ethnic groups are among those particularly susceptible to such conditions
associated with poverty as malaria, tuberculosis, HIV/AIDS, diarrhoeal and
respiratory diseases, malnutrition, high infant and maternal mortality rates,
and low life expectancy at birth".[11] Apart from not having any
advantages from eventually existing research output, indigenous communities
could not bring up the capital for the purchase of such medicaments or
therapies.
The
immanent existent indirect benefit of having the potential chance to heal or to
better examine diseases is thus of no significance for indigenous donors. But
immanent for indigenous people is the danger of being infected by an introduced
and spread pathogenic western germ against which they have no power of
resistance.[12] "It is a.... generally accepted fact that without the
preparation of a constant medical care one third or even more of the original
inhabitants die in the first five years after first contact.[13] This potential thread - in the
context of access to isolated living indigenous communities - should be
reconsidered in the discussion about regulation of access.
Out of
these thoughts we would like to correct the second thesis to that effect that
it says: Actors and actions in the "industrialised world" are dominated by
an economic orientation. The economic calculation in terms of aspiration for
individual profit dominates the reasons for acting. Economically oriented
acting does not preclude the maintenance of ethic, social and ecological principles
of the own culture and for the benefit of the own society, which are immanently
given. In view of foreign communities, especially indigenous people we find
imbalanced estimations.
An
immanent existing indirect benefit at the level of scientific output is –
as mentioned above – not relevant for the indigenous population.
But considering the dimension of the conflict process then it crystallizes some
kind of indirect benefit for the indigenous people. This indirect benefit
refers to an aspect of the positive consequences of conflicts we mentioned in
the first thesis of this paper. We
refer to the positive effects of the discussion about property rights, access
and benefit sharing in relation to genetic resources, which was enforced,
aroused through the Convention on Biological Diversity from 1992. These
discussions induced a process in the developing countries and especially among
the indigenous representatives, which was highly beneficial for the assertion
of the indigenous peoples from today's point of view. This process started with
the dispute about the regulation of the ănational sovereignty" over genetic
resources (CBD Art. 15)[14]:
"In the CBD, access to and transfer of genetic
resources and technologies (including indigenous and traditional technologies)
are assumed to be basic rights of states. But Indigenous peoples consider this
a problematic issue that must be negotiated with local communities, whose
rights are enumerated by international agreements and laws to which these same
states are parties".[15]
The
dispute with the conflict about the property rights of the genetic resources of
the indigenous populations provoke the indigenous to make public their own
rights and interests on the local, national and international levels and to
make the world listen to them. In the past twelve years processes of unionizing
and organizing indigenous communities and ethnic groups and of active
participation of indigenous actors on many levels up to UN-Organisations took
place. At various opportunities the indigenous representatives expressed their
demand to consider and respect their right to self-determination and full
participation in international processes, as well as their status as right
holders and not of mere stakeholders for example in the "Closing Declaration Sixth
Conference of the Parties of the Convention on Biological Diversity, The Hague,
19 April 2002"[16], and in the year 2003 in Durban in
"The Indigenous Peoples' Declaration to the World Parks Congress"[17] and additionally this year during
the COP7 in Kuala Lumpur in the "Statement to the Conference of the Parties
regarding the Ad Hoc Open-Ended Working Group on Access and Benefit Sharing
(Agenda Item 19.11)[18].
The
indigenous peoples are defending their property rights against external
interests – and may it be in an extreme case through the complete
exclusion of others in using their resources. Thus the indigenous populations
are little by little becoming almost equal partners and therefore we consider
this achievement in some way as an indirect benefit or positive effect of the
conflict about access and benefit sharing.
3rd Thesis
Economic acting, which is
ethically, socially and ecologically aligned, might lead to a significant gain
in economic efficiency.[19]
The
implementation of and the compliance to voluntary codes of conduct such as
corporate governance not only leads to a significant increase of economic
efficiency but contributes also to break down the existing asymmetry between
the disputing antagonists and the proximate confrontations.
The
redesign of disposal rights in terms of granting populations the status of
right holders leads to a fortification of theses social actors
(collective of patients, indigenous communities, minorities etc.) within the
field of a free market economy.
An
improvement of the economic positions of the aforementioned populations might
basically lead to the breakdown of asymmetric positions of power and might open
the port to a frank and emancipated communication between the different groups
and thus to conflict solution.
Conclusions
A regulatory model which regards populations all over
the world as equal market participants, that respects the right of
self-determination and recognizes the right to full and effective participation
and that guarantees the property rights of the different populations could be
an important contribution to conflict solution in the context of access and
benefit sharing for research in population based research.
Associated Press: Diseases threaten Brazilian tribe. Monday, February 5,
2001
BRECHT, Christine; Sybilla NOKOLOW: Displaying the Invisible: Volkskrankheiten
on Exhibition in Imperial Germany.
Stud. Hist. Phil. Biol. & Biomed. Sci., Vol. 31, No. 4, pp. 511–530, 2000
CEVALLOS, Diego: Abortan convenios de bioprospeccin. Tierramrica, 22.
Octubre 2000
– www.tierramerica.net/2000/1022/articulo.html
Closing Declaration Sixth Conference of the Parties of the Convention on
Biological Diversity, The Hague 19th April 2002 http://www.nciv.net/engels/IIFB/Closing%20Decl.Cop.htm
Convention on Biological Diversity, 5th June
1992http://www.biodiv.org/doc/legal/cbd-en.pdf
CUNNINGHAM, Hilary und Stephen SCHARPER: Proyecto Genoma Humano.
Patentar lo 'primitivo'. In: Revista del Sur 55. Montevideo 4/1996www.revistadelsur.org.uy/revista.055/Biotecnologia.html
GETTKANT, Andreas: Umsetzung der
Biodiversittskonvention. Ein Projekt derdeutschen Entwicklungszusammenarbeit. Eschborn: GTZ 1999
IDRC: Appendix 1. The Human Genome
Diversity Project. ID 30136, 2003: 7
http://web.idrc.ca/en/ev-30136-201-1-DO_TOPIC.htm
International Indian Treaty
Council: Statement to the Conference of the Parties regarding the Ad Hoc
Open-Ended Working Group on Access and Benefit Sharing (Agenda Item 19.11). The
Indigenous Peoples' Declaration to the World Parks Congress in Durban 2003 www.treatycouncil.org/section_211812142.htm
Nationaler
Ethikrat: Biobanken fr die Forschung. Stellungnahme. Berlin: NER 2004
NOVY, Andreas: Internationale Politische
konomie. Mit Beispielen aus Lateinamerika. Wirtschaftsuniversitt Wien. Wien: LASON 2004http://www.lateinamerika-studien.at/content/wirtschaft/ipo/ipo-937
RAGHAVAN, Chakravarthi: Patentes. Trasnacionales
al asalto de la biodiversidad.
In: Tercer Mundo Econmico.. No. 75, Montevideo: Red del Tercer Mundo
11/1995
Sekretariat
des Runden Tisches Verhaltenskodizes c/o Deutsche Gesellschaft fr Technische
Zusammenarbeit (GTZ) Hrsg.: Ratgeber Verhaltenskodizes zu Sozialstandards. Eschborn: GTZ 2004
Statement to the Conference of the Parties regarding the Ad Hoc
Open-Ended Working Group on Access and Benefit Sharing (Agenda Item 19.11, COP7
in Kuala Lumpur www.nciv.net/Frans/COP/Docop7/ABS%20Opening%20Statement%2012%20Feb%202004%20Final%20English.doc
TIERNEY,
Patrick: Verrat am Paradies. Journalisten und Wissenschaftler zerstren das
Leben am Amazonas. Mnchen, Zrich: Piper 2002
WHO: FIFTY-FIFTH WORLD HEALTH ASSEMBLY A55/35, Provisional
agenda item 19: 2002 www.who.int/gb/EB_WHA/PDF/WHA55/ea5535.pdf
WZB (Wissenschaftszentrum Berlin fr
Sozialforschung): Results presented by Working Group II at Montreux. 2002
http://www.wz-berlin.de/ipr-dialogue/argumentations/tk/tk4.htm
[3] Which is called
ăgenetic fever" in analogy to ăgold fever" by the indigenous and is decried as
genetic colonisation by the indigenous peoples. The most famous example is the
- now deposed – ăHuman Genetic Diversity Project (HGDP)" from 1991.
[4] For the affected
population of the developing countries the human genetic research is a new
danger, which might lead to control and
depression by a dominant population.
[5] See: NOVY 2004
[6] These
considerations are in contrast with the utilitarianism approach (NOVY 2004)
[7] see: GETTKANT
1999:1
[8] see: CEVALLOS
2000; CUNNINGHAM & SCHARPER 1996; RAGHAVAN 1995
[9] ăHowever, it is by no means
coincidental that there is no counterpart to the term Volkskrankheiten
in the English and
French languages. Rather, the reason for this can be found in the divergent
histories of political and social languages; in this respect, the linguistic
difference is closely linked to the history of the formation of the
nation-state. The search for the genesis and the meaning of the term Volkskrankheiten
thus leads into the
heart of the history of the key terms 'people/folk', 'nation', 'nationalism',
'mass' (Volk, Nation, Nationalismus, Masse), which correspond to terms in English and
French but are by no means identical with them.
In contrast to the medical and
scientific term 'infectious diseases', which
super-seded (but did not abolish) the language of scourges and epidemics in the
wake of the validation and establishment of the bacteriological conception of
disease, the term Volkskrankheiten was a political and social term
charged with meanings
that changed over time" (BRECHT
& NIKOLOW 2000: 518)
[10] Nationaler Ethikrat 2004: 12
[11] WHO 2002:3
[12] "Over the past 20
years, malaria and other diseases that arrived with prospectors and other
invaders have killed at least 3,000 Indians on the reservation's Brazilian
side. About a quarter of the nearly 13,000 Indians who live in Brazil came down
with malaria last year alone, according to the National Health Foundation"
(Associated Press: Monday, February 5, 2001).
[13] The journalist
Patrick Tierney writes in his book ăDarkness in El Dorado" about ă...the
dangers which contact with a foreigner, the gifts, pistols, cameras and future
plans for academic research means for the Indians". (TIERNEY 2002: 417).
[14]"1.
Recognizing the sovereign rights of States over their natural resources, the
authority to determine access to
genetic resources rests with the national governments and is subject to
national legislation" (CBD Art. 15. Access to Genetic Resources, 1992: 9).
[14] WZB 2002
[16] "International Indigenous Forum on
Biodiversity" (Den Hague April 2002):
1.
"Madame Chair, Indigenous Peoples have the right to self-determination. This
right is the basis of our recognition as a Major Group in Agenda 21 and other
instruments that emerged from the 1992 Rio Summit. Agenda 21 recognises the
right to full and effective participation in international processes that
affect us. That is why we are here. We believe that the provisions and programs
approved by the Parties of this Conference affect the future of the Peoples of
the Planet. For us, these discussions are a matter of life and death.
2.
Indigenous Peoples are rights holders and not mere interested parties. We did
not come here to negotiate our rights, but rather to guarantee the obligations
of the Parties with respect to our Peoples".
[18] "Indigenous peoples stand firmly
upon our rights of self-determination.
Our rights of self-determination are fundamental to the freedom to carry
out our responsibilities in accordance with our cultural values and customary
laws. All decisions in the CBD process must recognize and protect the
fundamental premise that Indigenous peoples are rights holders with
proprietary, inherent, and inalienable rights to our Indigenous knowledge and
biological resources. The rights of Indigenous peoples, as the owners of their
territories, exist and stand independent of the discussions on any proposed
international regime".
[19] For example in the
form of:
á
Increased identification of the people concerned (dedication, power
of innovation etc.)
á
Improvement of image and confidence
á
Encouragement of current value
á
Advancement of product quality
á
Improvement of competitive advantage and market position.
(see: GTZ 2004: 5 – 7)